Influence of interleukin-10 on the interleukin-1 receptor antagonist/interleukin-1β ratio in the colonic mucosa of ulcerative colitis

被引:33
作者
Ishizuka, K [1 ]
Sugimura, K [1 ]
Homma, T [1 ]
Matsuzawa, J [1 ]
Mochizuki, T [1 ]
Kobayashi, M [1 ]
Suzuki, K [1 ]
Otsuka, K [1 ]
Tashiro, K [1 ]
Yamaguchi, O [1 ]
Asakura, H [1 ]
机构
[1] Niigata Univ, Sch Med, Dept Internal Med, Div 3, Niigata 9518510, Japan
关键词
interleukin-1; interleukin-1 receptor antagonist; interleukin-10; polymorphism; ulcerative colitis;
D O I
10.1159/000051906
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
A decrease in the ratio of IL-1ra/IL-1 beta produced regionally by the colonic mucosa of patients with ulcerative colitis (UC) is believed to play a role in the pathogenesis of UC. To investigate factors influencing intramucosal IL-1ra/IL-1 beta ratios, we evaluated polymorphism of the IL-1ra gene and the production of mucosal cytokines in Japanese patients with UC. Colonic biopsy specimens of mucosal tissue were placed in organ cultures for 24 h. Then, the supernatant concentrations of IL-1 beta, IL-1ra, IL-8, IL-4, IL-10, and TGF-B were assayed by ELISA. Genomic DNA was extracted from patient peripheral blood samples, then IL-1ra gene polymorphism was determined using PCR amplification. The mucose from patients with active stage UC showed a tendency toward a decreased IL-1ra/IL-1 beta ratio. In the resolving stage, IL-1ra/IL-1 beta ratios increased with increasing IL-10 and TGF-beta concentrations. The addition of human recombinant IL-10 to the culture supernatants produced concentration-dependent inhibition of IL-1 beta. In Japanese patients with UC, the IL-1ra allele gene 2 phenotype had no effect on the IL-1ra/IL-1 beta ratio. Our findings suggest that a relative deficiency of IL-10 in patients with UC may contribute to persistent inflammatory changes. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:22 / 27
页数:6
相关论文
共 34 条
[1]   Imbalance of the interleukin 1 system in colonic mucosa - association with intestinal inflammation and interleukin 1 receptor agonist genotype 2 [J].
Andus, T ;
Daig, R ;
Vogl, D ;
Aschenbrenner, E ;
Lock, G ;
Hollerbach, S ;
Kollinger, M ;
Scholmerich, J ;
Gross, V .
GUT, 1997, 41 (05) :651-657
[2]   In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease [J].
Autschbach, F ;
Braunstein, J ;
Helmke, B ;
Zuna, I ;
Schürmann, G ;
Niemir, ZI ;
Wallich, R ;
Otto, HF ;
Meuer, SC .
AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (01) :121-130
[3]  
BIOQUE G, 1995, CLIN EXP IMMUNOL, V102, P379
[4]  
Blakemore AIF, 1996, HUM GENET, V97, P369, DOI 10.1007/BF02185776
[5]   INTERLEUKIN-1 RECEPTOR ANTAGONIST GENE POLYMORPHISM AS A DISEASE SEVERITY FACTOR IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
BLAKEMORE, AIF ;
TARLOW, JK ;
CORK, MJ ;
GORDON, C ;
EMERY, P ;
DUFF, GW .
ARTHRITIS AND RHEUMATISM, 1994, 37 (09) :1380-1385
[6]   T cells of the human intestinal lamina propria are high producers of interleukin-10 [J].
Braunstein, J ;
Qiao, L ;
Autschbach, F ;
Schurmann, G ;
Meuer, S .
GUT, 1997, 41 (02) :215-220
[7]  
CASINIRAGGI V, 1995, J IMMUNOL, V154, P2434
[8]  
Chabot S, 1999, J IMMUNOL, V162, P6819
[9]  
CLAY FE, 1994, HUM GENET, V94, P407
[10]   INTERLEUKIN-1 (IL-1) GENE-EXPRESSION, SYNTHESIS, AND EFFECT OF SPECIFIC IL-1 RECEPTOR BLOCKADE IN RABBIT IMMUNE-COMPLEX COLITIS [J].
COMINELLI, F ;
NAST, CC ;
CLARK, BD ;
SCHINDLER, R ;
LLERENA, R ;
EYSSELEIN, VE ;
THOMPSON, RC ;
DINARELLO, CA .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (03) :972-980